Abstract
The JAK-STAT pathway, originally identified in the interferon signaling pathway, has been shown to play an essential role in cytokine-mediated biological responses mainly through the analysis of knockout mice. The JAK family consists of four members (Jak1-3 and Tyk2), and the STAT family consists of seven members (Stat1–4, Stat5a, Stat5b, and Stat6). The JAK family of proteins plays an essential role mediated by cytokine receptors, whereas STAT proteins are responsible for their specific cytokines. In addition, there is a considerable body of evidence demonstrating that activity of the JAK-STAT pathway is regulated by several mechanisms, including the sacs family of proteins induced by activation of the JAK-STAT pathway. Gene targeting of the SOCS family revealed that individual sacs proteins negatively regulate some cytokine-mediated signaling pathways.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akaishi H, Takeda K, Kaisho T, Shineha R, Satomi S, Takeda J, Akira S. (1998) Defective IL-2 mediated IL-2 receptor α chain expression in Stat3-deficient T lymphocytes. Int Immunol 10:1747–1751
Akimoto T, Numata F, Tamura M, Takata Y, Higashida N, Takashi T, Takeda K, Akira S (1998) Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in STAT6-deficient mice. J Exp Med 187:1537–1542
Alexander WS, Starr R, Fenner JF, Scott CL, Handman E, Sprigg NS, Corbin JE, Cornish AL, Darwiche R, Owczarek CM, Kay TWH, Nicola NA, Hertzog PJ, Metcalf D, Hilton DJ (1999) SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98:597–608
Alonzi T, Maritano D, Gorgoni B, Rizzuto G, Libert C, Poli, V (2001) Essential role of STAT3 in the control of the acute-phase response as revealedby inducible gene inactivation [correction of activation] in the liver. Mol Cell Biol 21: 1621–1632
Alonzi T, Middleton G, Wyatt S, Buchman V, Betz VA, Müller W, Musiani P, Poli V, Davies AM (2001) Role of STAT3 and PI 3-kinase/Akt in mediating the survival actions of cytokines on sensory neurons. Mol Cell Neurosci 18:270–282
Arora T, Liu B, He H, Kim J, Murphy TL, Murphy KM, Modlin RL, Shuai K (2003) PIASx Is a Transcriptional co-repressor of signal transducer and activator of transcription 4. J Biol Chem 278:21327–21330
Azam M, Lee C, Strehlow I, Schindler C (1997) Functionally distinct isoforms of STAT5 are generated by protein processing. Immunity 6:691–701
Becker S, Groner B, Muller CW (1998) Three-dimensional structure of the Stat3β homodimer bound to DNA. Nature 394:145–151
Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, Holland G, Thompson-Snipes L, Leach MW, Rennick D (1996). Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 98:1010–1020
Bowman T, Garcia R, Turkson J, Jove R (2000) STATs in oncogenesis. Oncogene 19:2474–2488
Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE Jr. (1999) Stat3 as a oncogene. Cell 98:295–303
Caldenhoven E, van Dijk TB, Solari R, Armstrong J, Raaijmakers JA, Lammers JW, Koenderman L, de Groot RP (1996). STAT3β, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J Biol Chem 271:13221–13227
Chapman RS, Lourenco P, Tonner E, Flint DJ, Seibert S, Takeda K, Akira S, Clarke AR, Watson CJ (1999) Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev 13:2604–2616
Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell JE Jr, Kuriyan J (1998) Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 93:827–839
Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, Shuai K. (1997) Specific inhibition of Stat3 signal transduction by PIAS3. Science 278:1803–1805
Croker BA, Krebs DL, Zhang JG, Wormald S, Willson TA, Stanley EG, Robb L, Greenhalgh CJ, Forster I, Clausen BE, Nicola NA, Metcalf D, Hilton DJ, Roberts AW, Alexander WS. (2003) SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 4, 540–545
David M, Chen HE, Goelz S, Lamer AC, Neel BG. (1995) Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 15:7050–7058
Duncan SA, Zhong Z, Wen Z, Darnell JE Jr (1997) Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Dev Dyn 208:190–198
Dupuis S, Dargemont C, Fieschi C, Thomassin N, Rosenzweig S, Harris J, Holland SM, Schreiber RD, Casanova JL (2001) Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 293:300–303
Durbin JE, Hackenmiller R, Simon MC, Levy DE (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84:443–450
Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A (1997) A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921–924
Gil MP, Bohn E, O’Guin AK, Ramana CV, Levine B, Stark GR, Virgin HW, Schreiber RD (2001) Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci USA 98: 6680–6685
Haque SJ, Harbor P, Tabrizi M, Yi T, Williams BR (1998) Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4-and IL-13-dependent signal transduction. J Biol Chem 273:33893–33896
Hayashi N, Matsui K, Tsutsui H, Osada Y, Mohamed RT, Nakano H, Kashiwamura S, Hyodo Y, Takeda K, Akira S, Hada T, Higashino K, Kojima S, Nakanishi K (1999) Kuppfer cells from Schistosoma mansoni-infected mice participate in the prompt type 2 differentiation of hepatic T cells in response to worm antigens. J Immunol 163:6702–6711
Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Silvennoinen O (1995) Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol 13:369–398
Ihle JN (1996) STATs: signal transducers and activators of transcript ion. Cell 84:331–334.
Imada K, Bloom ET, Nakajima H, Horvath-Arcidiacono JA, Udy GB, Davey HW, Leonard WJ (1998) Stat5b is essential for natural killer cell-mediated proliferation and cytotoxic activity. J Exp Med 188:2067–2074
Jiao H, Berrada K, Yang W, Tabrizi M, Platanias LC, Yi T (1996) Direct association with and dephosphorylation of Jak2 kinase by the SH2 domain-containing protein tyrosine phosphatase SHP-1. Mol Cell Biol 16:6985–6992
Kaplan MH, Schindler U, Smiley ST, Grusby MJ (1996) Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4: 313–319
Kaplan MH, Sun YL, Hoey T Grusby MJ (1996) Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174–177
Kaplan MH, Wurster AL, Grusby MI (1998) A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type 1 cells. J Exp Med 188: 1191–1196
Kaplan MH, Whitfield JR, Boros DL, Grusby MJ (1998) Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J Immunol 160:1850–1856
Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD (1998) Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA 95:7556–7561
Karaghiosoff M, Neubauer H, Lassnig C, Kovarik P, Schindler H, Pircher H, McCoy B, Bogdan C, Decker T, Brem G, Pfeffer K Muller M (2000) Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity 13:549–560
Karaghiosoff M, Steinborn R, Kovarik P, Kriegshauser G, Baccarini M, Donabauer B, Reichart U, Kolbe T, Bogdan C, Leanderson T, Levy D, Decker T, Muller M (2003) Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat Immunol 4:471–477
Kawazoe Y, Naka T, Fujimoto M, Kohzaki H, Morita Y, Narazaki M, Okumura K, Saitoh H, Nakagawa R, Uchiyama Y, Akira S, Kishimoto T. (2001) Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-I) phosphorylation. J Exp Med 193:263–269
Kieslinger M, Woldman I, Moriggl R, Hofmann J, Marine JC, Ihle JN, Beug H, Decker T (2000) Anti-apoptotic activity of Stat5 required during terminal stages of myeloid differentiation. Genes Dev 14:232–244
Kim TK, Maniatis T (1996) Regulation of interferon-γ-activated STAT1 by the ubiquitinproteasome pathway. Science 273:1717–1719
Kim H, Hawley TS, Hawley RG, Baumann H (1998) Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acutephase plasma protein genes in hepatic cells. Mol Cell Biol 18:1525–1533
Kinjyo I, Hanada T, Inagaki-Ohara K, Mori H, Aki D, Ohishi M, Yoshida H, Kubo M, Yoshimura A (2002) SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17:583–591
Kishimoto T, Taga T, Akira S (1994) Cytokine signal transduction. Cell 76:253–262
Klingmuller U, Lorenz U, Cantley LC, Neel BG, Lodish HF (1995) Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferativesignals. Cell 80:729–738
Kobayashi M, Kweon M, Kuwata H, Kiyono H, Takeda K, Akira S (2003) Toll-like receptor-dependent IL-12p40 production causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J Clin Invest 111:1297–1308
Kralovics R, Indrak K, Stopka T, Berman BW, Prchal JF, Prchal JT (1997) Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias. Blood 90:2057–2061
Krebs DL, Uren RT, Metcalf D, Rakar S, Zhang JG, Starr R, De Souza DP, Hanzinikolas K, Eyles J, Connolly LM, Simpson RJ, Nicola NA, Nicholson SE, Baca M, Hilton DJ, Alexander WS (2002) SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation. Mol Cell Biol 22:4567–4578
Kritikou EA, Sharkey A, Abell K, Came PJ, Anderson E, Clarkson RW, Watson CJ (2003) A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland. Development 130:3459–3468
Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263–274
Lang R, Pauleau AL, Parganas E, Takahashi Y, Mages J, Ihle IN, Rutschman R, Murray PJ (2003) SOCS3 regulates the plasticity of gp130 signaling. Nat Immunol 4:546–550
Lentsch AB, Kato A, Davis B, Wang W, Chao C, Edwards MJ (2001) STAT4 and STAT6 regulate systemic inflammation and protect against lethal endotoxemia. J Clin Invest 108:1475–1482
Leonard W, O’Shea JJ (1998) JAKS and STATS: Biological implications. Annu Rev Immunol 16: 293–322
Li W, Liang X, Kellendonk C, Poli V, Taub R. (2002) STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 277:28411–28417
Lindeman GJ, Wittlin S, Lada H, Naylor MJ, Santamaria M, Zhang JG, Starr R, Hilton DJ, Alexander WS, Ormandy CJ, Visvader (2001) SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor-deficient mice. Genes Dev 15:1631–1636
Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD, Shuai K (1998) Inhibition of Stat1-mediated gene activation by PIAS1. Proc Natl Acad Sci USA 95:10626–10631
Liu B, Gross M, ten Hoeve J, Shuai K (2001) A transcriptional corepressor of Stat1 with an essential LXXLL signature motif. Proc Natl Acad Sci USA 98:3203–3207
Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L (1997) Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 11:179–186
Mahalingam S, Karupiah G, Takeda K, Akira S, Matthaei KI, Foster PS (2001) Enhanced resistance in STAT6-deficient mice to infection with ectromelia virus. Proc Natl Acad Sci USA 98:6812–6817
Marine J-C, Topham DJ, McKay C, Wang D, Parganas E, Stravopodis D, Yoshimura A, Ihle JN (1999) SOCSI deficiency causes a lymphocytedependent perinatal lethality. Cell 98:609–616
Masuhara M, Sakamoto H, Matsumoto A, Suzuki R, Yasukawa H, Mitsui K, Wakioka T, Tanimura S, Sasaki A, Misawa H, Yokouchi M, Ohtsubo M, Yoshimura A (1997) Cloning and characterization of novel CIS family genes. Biochem Biophys Res Commun 239:439–446
McLemore ML, Grewal S, Liu F, Archambault A, Poursine-Laurent J, Haug J, Link DC (2001) STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity 14: 193–204
Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD (1996) Targeted disruption of the Stat1 gene in mice reveals unexpected physiological specificity in the JAK-STAT pathway. Cell 84:431–442
Metcalf D, Greenhalgh CJ, Viney E, Willson TA, Starr R, Nicola NA, Hilton DJ, Alexander WS. (2000) Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405:1069–1073
Migone TS, Cacalano NA, Taylor N, Yi T, Waldmann TA, Johnston JA. (1998) Recruitment of SH2-containing protein tyrosine phosphatase SHP-l to the interleukin 2 receptor; loss of SHP-1 express ion in human T-lymphotropic virus type I-transformed T cells. Proc Natl Acad Sci USA 95:3845–3850
Moriggl R, Topham DJ, Teglund S, Sexl V, McKay C, Wang D, Hoffmeyer A, van Deursen J, Sangster MY, Bunting KD, Grosveld GC, Ihle JN. (1999) Stat5 is required for IL-2 induced cell cycle progression of peripheral T cells. Immunity 10:249–259
Morita Y, Naka T, Kawazoe Y, Fujimoto M, Narazaki M, Nakagawa R, Fukuyama H, Nagata S, Kishimoto T (2000) Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts. Proc Natl Acad Sci USA 97:5405–5410
Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T (1997) Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924–929
Naka T, Matsumoto T, Narazaki M, Fujimoto M, Morita Y, Ohsawa Y, Saito H, Nagasawa T, Uchiyama Y, Kishimoto T (1998) Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc Natl Acad Sci USA 95:15577–15582
Naka T, Tsutsui H, Fujimoto M, Kawazoe Y, Kohzaki H, Morita Y, Nakagawa R, Narazaki M, Adachi K, Yoshimoto T, Nakanishi K, Kishimoto T (2001) SOCS-1ISSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo. Immunity 14:535–545
Nakagawa R, Naka T, Tsutsui H, Fujimoto M, Kimura A, Abe T, Seki E, Sato S, Takeuchi O, Takeda K, Akira S, Yamanishi K, Kawase I, Nakanishi K, Kishimoto T (2002) SOCS-1 participates in negative regulation of LPS responses. Immunity 17:677–687
Nakajima H, Liu X-W, Wynshaw-Boris A, Rosenthal LA, Imada K, Finbloom DS, Hennighausen L, Leonard WJ (1997) An indirect effect of Stat5a in IL-2 induced proliferation: a critical role for Stat5a in IL-2 mediated IL-2 receptor α chain induction. Immunity 7:691–701
Neubauer H, Cumano A, Mueller M, Wu H, Huffstadt U, Pfeffer K (1998) Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 93:397–409
Nguyen KB, Watford WT, Salomon R, Hofmann SR, Pien GC, Morinobu A, Gadina M, O’Shea JJ, Biron CA (2002) Critical role for STAT4 activation by type 1 interferons in the interferon-γ response to viral infection. Science 297:2063–2066
Nosaka T, Van Deursen JM, Tripp RA, Thierfelder WE, Witthuhn BA, McMickle AP, Doherty PC, Grosveld GC, Ihle JN (1995) Defective lymphoid development in mice lacking Jak3. Science 270:800–802
Parganas E, Wang D, Stravopidis D, Topham D, Marine JC, Teglund S, Vanin EF, Bodner S, Colamonici OR, van Deursen JM, Gorsveld G, Ihle JN (1998) Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93:385–395
Park SY, Saijo K, Takahashi T, Osawa M, Arase H, Hirayama N, Miyake K, Nakauchi H, Shirasawa T Saito T (1995) Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 3:771–782
Philp JA, Burdon TG, Watson CJ (1996) Differential activation of STATs 3 and 5 during mammary gland development. FEBS Lett 396:77–80
Rajewsky K, Gu H, Kuhn R, Betz UA, Muller W, Roes J, Schwenk F (1996) Conditional gene targeting. J Clin Invest 98:600–603
Ramana CV, Grammatikakis N, Chernov M, Nguyen H, Goh KC, Williams BR, Stark GR (2000) Regulation of c-myc expression by IFN-γ through Stat1-dependent and-independent pathways. EMBO J 19:263–272
Ramana CV, Gil MP, Schreiber RD, Stark GR (2002) Stat1-dependent and-independent pathways in IFN-γ-dependent signaling. Trends Immunol 23:96–101
Riley JK, Takeda K, Akira S, Schreiber RD (1999) Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J Biol Chem 274:16513–16521
Rodig SJ, Meraz MA, White JM, Lampe PA, Riley JK, Arthur CD, King KL, Sheehan KC, Yin L, Pennica D, Johnson EM Jr, Schreiber RD (1998) Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 93: 373–383
Rodriguez-Sosa M, David JR, Bojalil R, Satoskar AR, Terrazas LI (2002) Cutting edge: susceptibility to the larval stage of the helminth parasite Taenia crassiceps is mediated by Th2 response induced via STAT6 signaling. J Immunol 168:3135–3139
Sachdev S, Bruhn L, Sieber H, Pichler A, Melchior F, Grosschedl (2001) PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEFI activity by sequestration into nuclear bodies. Genes Dev 15:3088–3103
Sano S, Itami S, Takeda K, Tarutani M, Yamaguchi Y, Miura H, Yoshikawa K, Akira S, Takeda J (1999) Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J 18:4657–4668
Sano S, Takahama Y, Sugawara T, Kosaka H, Itami S, Yoshikawa K, Miyazaki J, van Ewijk W, Takeda J (2001) Stat s in thymic epithelial cells is essential for postnatal maintenance of thymic architecture and thymocyte survival. Immunity 15:261–273
Schindler C, Darnell JE Jr (1995) Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 65:621–651
Schmidt D, Muller S (2002) Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc Natl Acad Sci USA 99:2872–2877
Schweizer U, Gunnersen J, Karch C, Wiese S, Holtmann B, Takeda K, Akira S, Sendtner M. (2002) J Cell Biol 156:287–297
Seki Y, Hayashi K, Seki N, Matsumoto A, Ransom J, Naka T, Kishimoto T, Yoshimura A, Kubo M (2002) Selective expression of suppressor of cytokine signaling-5 (SOCS5) in type 1 helper T cell negatively regulates IL-4 dependent STAT6 activation. Proc Natl Acad Sci USA 99:13003–13008
Seki YI, Inoue H, Nagata N, Hayashi K, Fukuyama S, Matsumoto K, Komine O, Hamano S, Himeno K, Inagaki-Ohara K, Cacalano N, O’Garra A, Oshida T, Saito H, Johnston JA, Yoshimura A, Kubo M (2003) Suppressor of cytokine signaling-3 (SOCS3) regulates onset and maintenance of type 2 helper T cell mediated allergic responses. Nat Med 9:1047–1054
Sexl V, Piekorz R, Moriggl R, Rohrer J, Brown MP, Bunting KD, Rothammer K, Roussel MF, Ihle JN (2000) Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl-and bcr/abl-induced transformation are independent of Stat5. Blood 96:2277–2283
Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD (2001) IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410:1107–1111
Sherman MA, Powell DR, Brown MA (2002) IL-4 induces the proteolytic processing of mast cell STAT6. J Immunol 169:3811–3818
Shimoda K, Kato K, Aoki K, Matsuda T, Miyamoto A, Shibamori M, Yamashita M, Numata A, Takase K, Kobayashi S, Shibata S, Asano Y, Gondo H, Sekiguchi K, Nakayama K, Nakayama T, Okamura T, Okamura S, Niho Y (2000) Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function. Immunity 13:561–571
Shimoda K, Tsutsui H, Aoki K, Kato K, Matsuda T, Numata A, Takase K, Yamamoto T, Nukina H, Hoshino T, Asano Y, Gondo H, Okamura T, Okamura S, Nakayama K, Nakanishi K, Niho Y, Harada M (2002) Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient mice. Blood 99:2094–2099
Shuai K (2000) Modulation of STAT signaling by STAT-interacting proteins. Oncogene 19:2638–2644
Shelburne CP, McCoy ME, Piekorz R, Sexl V, Roh KH, Jacobs-Helber SM, Gillespie SR, Bailey DP, Mirmonsef P, Mann MN, Kashyap M, Wright HV, Chong HJ, Bouton LA, Barnstein B, Ramirez CD, Bunting KD, Sawyer ST, Lantz CS, Ryan JJ (2003) Stat5 expression is critical for mast cell development and survival. Blood 102:1290–1297
Simpson SJ, Shah S, Comiskey M, de long YP, Wang B, Mizoguchi E, Bhan AK, Terhorst C (1998) T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/ signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon γ expression by T cells. J Exp Med 187:1225–1234
Socolovsky M, Fallon AE, Wang S, Brugnara C, Lodish HF (1999) Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/-mice: A direct role for Stat5 in Bcl-XL induction. Cell 98:181–191
Stamm LM, Raisanen-Sokolowski A, Okano M, Russell ME, David JR, Satoskar AR (1999) Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous Leishmaniasis. J Immunol 161:6180–6188
Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ (1997) A family of cytokine inducible inhibitors of signalling. Nature 387:917–921
Starr R, Metcalf D, Elefanty AG, Brysha M, Willson TA, Nicola NA, Hilton DJ, Alexander WS (1998) Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc Natl Acad Sci USA 95:14395–14399
Strous GJ, van Kerkhof P, Govers R, Ciechanover A, Schwartz AL (1996) The ubiquitin conjugation system is required for ligand-induced endocytosis and degradation of the growth hormone receptor. EMBO J 15:3806–3812
Suzuki K, Nakajima H, Kagami S, Suto A, Ikeda K, Hirose K, Hiwasa T, Takeda K, Saito Y, Akira S, Iwamoto I (2002) Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism. J Exp Med 196:27–38
Takahashi Y, Carpino N, Cross JC, Torres M, Parganas E, Ihle JN (2003) SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. EMBO J 22:372–384
Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S (1996) Essential role of Stat6 in IL-4 signalling. Nature 380:627–630
Takeda K, Kamanaka K, Tanaka T, Kishimoto T, Akira S (1996) Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J Immunol 157:3220–3222
Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T, Akira, S (1997) Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 94:3801–3804
Takeda K, Kaisho T, Yoshida N, Takeda J, Kishimoto T, Akira S (1998) Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: Generation and characterization of T cell-specific Stat3-deficient mice. J Immunol 161:4652–4660
Takeda K, Clausen B, Kaisho T, Tsujimura T, Terada N, Förster I, Akira S (1999) Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10:39–49
Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335–376
Taniguchi T (1995) Cytokine signal through nonreceptor protein tyrosine kinases. Science 268:251–255
Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G, Ihle JN (1998) Stat5a and Stat5b proteins have essential roles and nonessential, or redundant, roles in cytokine responses. Cell 93:841–850
Tekkanat KK, Maassab HF, Cho DS, Lai JJ, John A, Berlin A, Kaplan MH, Lukacs NW (2001) IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent. J Immunol 166:3542–3548
Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DA, Doherty PC, Grosveld G Ihle JN (1996) Requirement for Stat4 in interleukin-12 mediated response of natural killer and T cells. Nature 382:171–174
Thomis DC, Gurniak CB, Tivol E, Sharpe AH, Berg LJ (1995) Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270:794–797
Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey DW (1997) Requirement of Stat5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 94:7239–7244
Wang D, Stravopodis D, Teglund S, Kitazawa J, Ihle JN (1996) Naturally occurring dominant negative variants of Stat5. Mol Cell Biol 16:6141–6148
Yasukawa H, Ohishi M, Mori H, Murakami M, Chinen T, Aki D, Hanada T, Takeda K, Akira S, Hoshijima M, Hirano T, Chien KR, Yoshimura A (2003) IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol 4:551556
Yeh TC, Dondi E, Uze G, Pellegrini S (2000) A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling. Proc Natl Acad Sci USA 97:8991–8996
Yoo JY, Huso DL, Nathans D, Desiderio S (2002) Specific ablation of Stat3beta distorts the pattern of Stat3-responsive gene expression and impairs recovery from endotoxic shock. Cell 108:331–344
Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE, Harris CC, Herman JG (2001) SOCS-l, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 28:29–35
Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG, Hara T, Miyajima A (1995) A novel cytokineinducible gene CIS encodes an SH2 containing protein that binds to tyrosinephosphorylated interleukin 3 and erythropoietin receptors. EMBO J 14:2816–2826
You M, Yu DH, Feng GS (1999) Shp-2 tyrosine phosphatase functions as a negative regulator of the interferonstimulated Jak/STAT pathway. Mol Cell Biol 19:2416–2424
Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y, Kim YB, Elmquist JK, Tartaglia LA, Kahn BB, Neel BG (2002) PTPIB regulates leptin signal transduction in vivo. Dev Cell 2:489–495
Zhang JG, Farley A, Nicholson SE, Willson TA, Zugaro LM, Simpson RJ, Moritz RL, Cary D, Richardson R, Hausmann G, Kile BJ, Kent SB, Alexander WS, Metcalf D, Hilton DJ, Nicola NA, Baca M (1999) The conserved SOCS box motif in suppressors of cytokine signaling binds elongins Band C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci USA 96:2071–2076
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag
About this chapter
Cite this chapter
Takeda, K., Akira, S. (2004). Biological Roles of the STAT Family in Cytokine Signaling. In: Gossen, M., Kaufmann, J., Triezenberg, S.J. (eds) Transcription Factors. Handbook of Experimental Pharmacology, vol 166. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18932-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-18932-6_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62361-5
Online ISBN: 978-3-642-18932-6
eBook Packages: Springer Book Archive